{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20241216",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "80599",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216578s004lbl.pdf",
              "date": "20241217",
              "type": "Label"
            },
            {
              "id": "80617",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/216578Orig1s004ltr.pdf",
              "date": "20241218",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20240831",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "79537",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/216578Orig1s003ltr.pdf",
              "date": "20240903",
              "type": "Letter"
            },
            {
              "id": "79559",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216578s003lbl.pdf",
              "date": "20240909",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230512",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "74246",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/216578Orig1s000ltr.pdf",
              "date": "20230515",
              "type": "Letter"
            },
            {
              "id": "74247",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216578s000lbl.pdf",
              "date": "20230515",
              "type": "Label"
            },
            {
              "id": "74616",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/216578Orig1s000TOC.html",
              "date": "20230623",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA216578",
      "sponsor_name": "ASTELLAS",
      "openfda": {
        "application_number": [
          "NDA216578"
        ],
        "brand_name": [
          "VEOZAH"
        ],
        "generic_name": [
          "FEZOLINETANT"
        ],
        "manufacturer_name": [
          "Astellas Pharma US, Inc."
        ],
        "product_ndc": [
          "0469-2460",
          "0469-2660",
          "0469-2760"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "FEZOLINETANT"
        ],
        "rxcui": [
          "2637141",
          "2637147"
        ],
        "spl_id": [
          "462f0a23-98d6-4154-b113-322008069743"
        ],
        "spl_set_id": [
          "cae9f798-24f9-4580-a4fc-e6c710cbda3c"
        ],
        "package_ndc": [
          "0469-2660-30",
          "0469-2660-90",
          "0469-2460-07",
          "0469-2460-28",
          "0469-2760-07",
          "0469-2760-28"
        ],
        "nui": [
          "N0000194090",
          "N0000194091"
        ],
        "pharm_class_epc": [
          "Neurokinin 3 Receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Neurokinin 3 Receptor Antagonists [MoA]"
        ],
        "unii": [
          "83VNE45KXX"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "VEOZAH",
          "active_ingredients": [
            {
              "name": "FEZOLINETANT",
              "strength": "45MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}